Editorial Comment to Restoring the glycosaminoglycans layer in recurrent cystitis: Experimental and clinical foundations

International Journal of Urology

Volumn 21, Issue 8, 2014, Pages 769-

  Yazawa, Satoshi ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CHONDROITIN SULFATE; FOSFOMYCIN; GLYCOSAMINOGLYCAN; HYALURONIC ACID; VISCOSUPPLEMENT;

ANTIBIOTIC THERAPY; DRUG EFFICACY; EDITORIAL; HUMAN; INFECTION PREVENTION; INTERSTITIAL CYSTITIS; PRIORITY JOURNAL; RECURRENT DISEASE; RECURRENT INFECTION; RISK FACTOR; SUBSTITUTION THERAPY; URINARY TRACT INFECTION; ANIMAL; CYSTITIS;

ANIMALS; CHONDROITIN SULFATES; CYSTITIS; HUMANS; HYALURONIC ACID; VISCOSUPPLEMENTS;

EID: 84905028494     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/iju.12449     Document Type: Editorial

References (5)

1. Cicione A, Cantiello F, Ucciero G etal. Restoring the glycosaminoglycans layer in recurrent cystitis: Experimental and clinical foundations. Int. J. Urol. 2014; 21: 763-768.
2. Madersbacher H, van Ophoven A, van Kerrebroeck PE. GAG layer replenishment therapy for chronic forms of cystitis with intravesical glycosaminoglycans-a review. Neurourol. Urodyn. 2013; 32: 9-18.
3. De Vita D, Antell H, Giordano S. Effectiveness of intravesical hyaluronic acid with or without chondroitin sulfate for recurrent bacterial cystitis in adult women: a meta-analysis. Int. Urogynecol. J. 2013; 24: 545-552.
4. Ronald A. The etiology of urinary tract infection: traditional and emerging pathogens. Am. J. Med. 2002; 113 (Suppl 1A): 14S-19S.
5. Torella M, Schettino MT, Salvatore S, Serati M, De Franciscis P, Colacurci N. Intravesical therapy in recurrent cystitis: a multi-center experience. J. Infect. Chemother. 2013; 19: 920-925.